Product Name PT-141; Cas No. 32780-32-8; Sequence AC-Nle-Asp-His-DPhe-Arg-Trp-Lys(cylic2-7); Molecular Formula C50H68N14O10; Molar Mass 1025.2 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. PT-141 is a melanocortin agonist for the treatment of sexual dysfunction.

Learn More

Product Name Sincalide; Cas No. 25126-32-3; Sequence Asp-Tyr(SO3H)-Met-Gly-Trp-Met-Asp-Phe-NH2; Molecular Formula C49H62N10O16S3; Molar Mass 1143.27 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Sincalide  is a cholecystokinetic drug administered by injection to aid in diagnosing disorders of the gallbladder and pancreas.

Learn More

Product Name Degarelix Acetate; Cas No. 214766-78-6; Sequence Ac-D2Nal-D4Cpa-3Pal-Ser-4Aph(Hor)-D4Aph(Cbm)-Leu-Lys(Ipr)-Pro-DAla-NH2; Molecular Formula C82H103ClN18O16; Molar Mass 1630.75 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Degarelix is used to treat prostate cancer,advanced hormone-dependent prostate carcinoma.

Learn More

Product Name Linaclotide; Cas No. 851199-59-2; Sequence H-Cys-Cys-Glu-Tyr-Cys-Cys-Asn-Pro-Ala-Cys-Thr-Gly-Cys-Tyr-OH cyclic(1-6),(2-10),(5-13)-tris(disulfide); Molecular Formula C59H79N15O21S6; Molar Mass 1526.74 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Linaclotide was approved for the treatment in adults of constipation-predominant irritable bowel syndrome and chronic idiopathic constipation.

Learn More

Product Name Liraglutide; Cas No. 204656-20-2; Sequence H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(N-ε-(Nα-Palmitoyl-L-γ-glutamyl))-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH; Molecular Formula C172H265N43O51; Molar Mass 3751.202 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Function: Liraglutide is for the treatment of diabetes type 2. Mechanism of actions: Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated to improve glycemic control in adults with type 2 diabetes mellitus, and to reduce the risk of heart attack, stroke and CV death in adults with type 2 diabetes and established CV disease. It was approved by the FDA on December 23, 2014 and by the European Medicines Agency on January 23, 2015, for adults with a body mass index (BMI) of 30 or greater (obesity) or a BMI of 27 or greater (overweight) who have at least one weight-related condition. Originator Company: Novo Nordisk Dosage for finished formulation: 18 mg/3ml Similar effect peptides: Exenatide, Semaglutide Generic API process in our company: Liraglutide is one of our main peptide projects, related documents will be submitted to the international FDA.

Learn More

Product Name Atosiban Acetate; Cas No. 90779-69-4; Sequence Mpa-D-Tyr(ET)-Ile-Thr-Asn-Cys-Pro-Orn-Gly-NH2(Cyclic1-6); Molecular Formula C43H67N11O12S2; Molar Mass 994.199 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Atosiban Acetate can postpone its imminent premature birth. Mechanism of action: Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra). Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. As a result, there is reduced release of intracellular, stored calcium from the sarcoplasmic reticulum of myometrial cells, and reduced influx of Ca2+ from the extracellular space through voltage gated channels. In addition, atosiban suppresses oxytocin-mediated release of PGE and PGF from the decidua. Originator Company: Ferring Pharmaceuticals Dosage for formulation: 7.5mg/ml Generic API process in our company: Atosiban Acetate is one of our main peptide projects, related documents will be submitted to the international FDA.

Learn More

Product Name Eptifibatide Acetate; Cas No. 148031-34-9; Sequence Mpr-Har-Gly-Asp-Trp-Pro-Cys-NH2(Mpr1&Cys7); Molecular Formula C35H49N11O9S2; Molar Mass 831.96 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Eptifibatide Acetate is mainly for the treatment of unstable angina, acute myocardial infarction

Learn More

Product Name Teriparatide Acetate; Cas No. 52232-67-4; Sequence H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH; Molecular Formula C181H291N55O51S2; Molar Mass 4117.72 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Teriparatide Acetate is for the treatment of osteoporosis, can promote bone growth.

Learn More

Product Name Carbetocin Acetate; Cas No. 37025-55-1; Sequence C(CH2CH2CH2CONH-Tyr（Me）-Ile-Gln-Asn-Cys）-Pro-Leu-Gly-NH2; Molecular Formula C45H69N11O12S; Molar Mass 988.162 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers reqirement. Captope oxytocin for selective epidural or spinal anesthesia after caesarean section to prevent uterine contraction fatigue and postpartum hemorrhage.

Learn More

Product Name Exenatide Acetate; Cas No. 141732-76-5; Sequence H-His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp-Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-Gly-Ala-Pro-Pro-Pro-Ser-NH2; Molecular Formula C184H282N50O60S; Molar Mass 4186.6 g/mol; Purity ≥98%; Impurity ≤0.5% ; Storage Temperature 2-8℃; Packing Size 1G/Bottle, 10G/Bottle,50G/Bottle or at customers requirement. Exenatide Acetate is Pseudomonas aeruginin drug which can mimic glucose-dependent insulin secretion enhancement and intestinal hypoglycemic other anti-hyperglycemic agents.

Learn More